IRadimed Stock Year Fund Signals Growth and Risk in 2026
A large fund trimmed its IRADIMED stake while the company posted a record quarter, sparking discussion about growth, ...
Discover the best timing for robo versus manual investing in 2026. This intro outlines criteria, costs, and expected outcomes to guide your choice.
26,911 articlesA large fund trimmed its IRADIMED stake while the company posted a record quarter, sparking discussion about growth, ...
In a watershed move, Alphabet will join the Dow, while Verizon exits, as investors weigh AI investments against stead...
January data show a pending home sales fall, signaling continued headwinds for buyers even as rates move modestly low...
Prices stay higher than a few years ago, eroding cash savings. A trio of ETFs—GLD, VTIP, and DBC—are positioned to he...
The Trade Desk prepares to report quarterly results as investors grapple with a steep stock drop, focusing on revenue...
Coinbase posts a fee-driven growth model with a robust moat, while MicroStrategy grapples with bitcoin volatility. Th...
A sharp February move put Remitly Global in the spotlight. This article breaks down the catalysts behind the rally, t...
A scorching June exposes the full cost of FNGU: a 0.95% fee plus stubborn volatility decay from daily leverage resets...
Oracle reports an 84% jump in cloud IaaS revenue and a customer-friendly BYOC GPU program as DCLA argues the company ...
As rates linger and real estate cycles shift, investors weigh VNQ and SCHH for income. This report compares yields, s...
Retail investors on Reddit have shifted to a cautious stance on Tesla as late-2025 results reveal delivery declines a...
Two leading cybersecurity ETFs are signaling different bets on digital defense. CIBR emphasizes software platforms, w...